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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe recruitment of endogenous adult neural stem cells for brain repair is a promising regenerative therapeutic strategy. This strategy in-
volves stimulation of multiple stages of adult neural stem cell development, including proliferation, self-renewal, and differentiation.
Currently, there is a lack of a single therapeutic approach that can act on these multiple stages of adult neural stem cell development
to enhance neural regeneration. Here we show that metformin, an FDA-approved diabetes drug, promotes proliferation, self-renewal,
and differentiation of adult neural precursors (NPCs). Specifically, we show that metformin enhances adult NPC proliferation and
self-renewal dependent upon the p53 familymember and transcription factor TAp73, while it promotes neuronal differentiation of these
cells by activating the AMPK-aPKC-CBP pathway. Thus, metformin represents an optimal candidate neuro-regenerative agent that
is capable of not only expanding the adult NPC population but also subsequently driving them toward neuronal differentiation by
activating two distinct molecular pathways.INTRODUCTION
The observation of adult neural stem cells in the
mammalian brain (Imayoshi et al., 2008; Reynolds and
Weiss, 1992; Zhao et al., 2008) suggested that these
stem cells could be mobilized for the repair of the injured
or degenerating brain. A growing body of literature shows
that adult neural stem cells are recruited in response to
neural injury or degeneration, representing an attempt
at endogenous repair (Kernie and Parent, 2010; Mitchell
et al., 2004). However, this level of endogenous repair
was not sufficient to repair the damaged brain. Thus,
extensive efforts are underway to harness endogenous
neural precursor cells (NPCs) as a novel regenerative ther-
apeutic strategy to treat neural injury or brain degen-
eration. The recruitment of endogenous adult NPCs
involves stimulation of multiple stages of adult NPC
development, including proliferation, self-renewal, and
differentiation. Thus, an optimal regenerative strategy
would stimulate both proliferation/self-renewal and
neuronal differentiation in order to generate sufficient
numbers of new neurons to replace those lost after brain
injury or degeneration.988 Stem Cell Reports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The AMetformin, an FDA (Food and Drug Administration)-
approved diabetes drug, was recently shown to promote
adult neurogenesis under both physiological and patholog-
ical conditions in vivo (Liu et al., 2014; Jin et al., 2014;
Wang et al., 2012). However, metformin has multiple
molecular actions (Pernicova and Korbonits, 2014), and
it is still not clear which ones are important for its neural
effects. For example, metformin activates atypical protein
kinase C (aPKC)-mediated CREB-binding protein (CBP)
phosphorylation to regulate gluconeogenic gene expres-
sion in liver cells and enhance embryonic murine and
human NPC differentiation (He et al., 2009; Wang et al.,
2012). Moreover, metformin increases the levels of the
p53 family member transcription factor TAp73 in cancer
cells (Engelmann et al., 2015; Rosenbluth et al., 2008),
and TAp73 is essential for adult NPC self-renewal and pro-
liferation (Fujitani et al., 2010), suggesting that this protein
might also be important for metformin’s effects in the
brain.
Here, we show that metformin treatment enhances both
proliferation/self-renewal and neuronal differentiation of
adultNPCs by activating twodifferentmolecular pathways.
Metformin increases adult NPC proliferation/self-renewaluthors
via TAp73 while it promotes neuronal differentiation by
activating the AMPK-aPKC-CBP pathway. Thus,metformin
represents an optimal neuroregenerative agent to recruit
endogenous neural stem cells to replace the loss of neural
cells after brain injury and degeneration.RESULTS
Metformin Enhances Proliferation/Self-Renewal and
Neuronal Differentiation of Adult NPCs
Previously, we showed that metformin, an FDA-approved
diabetes drug, promotes embryonic murine and human
NPC differentiation in culture and adult neurogenesis
in vivo (Wang et al., 2012). To ask whether metformin
acts on multiple stages of adult neural precursor develop-
ment to increase adult murine neurogenesis in vivo, we
used adult subventricular zone (SVZ) neurosphere cultures
as amodel system to assess functional roles ofmetformin in
regulating the proliferation, self-renewal, and neuronal dif-
ferentiation of adult NPCs. First, we examined primary
neurosphere formation. Metformin (500 nM), added to
freshly isolated SVZ NPCs for 6 days, robustly increased
the number and size of primary neurospheres, indicators
of self-renewal and proliferation, respectively (Figures 1A–
1C). Metformin treatment of primary neurospheres also
enhanced the number and size of secondary and tertiary
neurospheres that were passaged every 4 days in the
absence of metformin (Figures 1D and 1E), indicating that
transient metformin treatment produces sustained NPC
self-renewal andproliferation responses. Second,we treated
dissociated NPCs derived from primary neurospheres with
metformin (1 mM) for 7 days. Metformin treatment signifi-
cantly increased the number of secondary neurospheres
(Figure 1F), again indicating augmented self-renewing
ability. Third, metformin significantly enhanced neuronal
differentiation (Figures 1G and 1H), as we have previously
published for embryonic NPCs (Wang et al., 2012). Finally,
we examined the effect of metformin on adult NPC sur-
vival. Monolayer-cultured adult NPCs were treated with
metformin (500 nM or 1 mM) for 2 days and assessed for
cleaved caspase-3 by immunostaining and condensed
nuclei. NPCs underwent apoptosis at a relatively low rate
(5%) inbothvehicle (PBS) andmetformin-treated cultures
at 500 nM, while apoptosis was decreased to 3% by 1 mM
metformin (Figure S1). Therefore, inhibition of apoptosis
was most likely not a major contributor to the robust in-
crease in the number and size of adult neurospheres
induced by metformin treatment.
We performed similar experiments in vivo, treating adult
mice with metformin intraperitoneally (i.p.; 200 mg/kg)
for 7 days, followed by a single bromodeoxyuridine
(BrdU) injection (i.p., 100 mg/kg to mark proliferatingStem CellNPCs). Mice were sacrificed 24 hr later to assess the total
number of BrdU-positive cells, which represent cycling
NPCs.Metformin treatment in vivo significantly expanded
the BrdU-positive NPC populations in the SVZ (Figures 1I
and 1J), consistent with the SVZ neurosphere data. We
also assessed the number of BrdU-positive cells in the
subgranular zone (SGZ) of the dentate gyrus, the other ma-
jor neurogenic region in the adult brain. As seen in the
SVZ, metformin increased the total relative number of
BrdU-positive cells in the SGZ (Figures 1K and 1L). Thus,
metformin promotesmultiple stages of adult NPC develop-
ment including proliferation, self-renewal, and neuronal
differentiation.
TAp73 Is Required for Metformin-Enhanced
Proliferation and Self-Renewal of Adult NPCs
Based on our previous work showing that aPKC-mediated
CBP phosphorylation at S436 is required for metformin-
stimulated differentiation of embryonic NPCs, we asked
whether this pathway was also involved in metformin-
induced proliferation and/or self-renewal of adult NPCs.
To do this, we performed adult neurosphere culture of
wild-type (WT) mice in the presence of a pan-PKC inhib-
itor, chelerythrine, and adult neurosphere culture from
a phospho-mutant CBPS436A knockin (CBPS436A-KI)
mouse strain, in which the aPKC-CBP pathway is deficient
due to the change of the serine (S) 436 residue to alanine (A)
in the aPKC phosphorylation site of the CBP allele (Zhou
et al., 2004). Quantification showed that chelerythrine
did not block the increase in neurosphere formation
induced by metformin (Figures 2A and 2B). Consistent
with these data, metformin enhanced the number of pri-
mary and secondary neurospheres cultured from adult
CBPS436A-KI as well as WT mice (Figures 2C and 2D).
These data suggest that metformin must act through a
second pathway to enhance the proliferation and self-
renewal of adult NPCs. In this regard, in cancer cells, met-
formin increases TAp73 levels (Engelmann et al., 2015;
Rosenbluth et al., 2008), and TAp73 is essential for adult
NPC self-renewal and proliferation (Fujitani et al., 2010).
Therefore, we asked whether metformin might act via
TAp73 to promote NPC self-renewal and proliferation.
First, we determined whether metformin increased TAp73
mRNA levels in NPCs as it does in cancer cells. qRT-PCR
of primary adult neurosphere mRNA showed that TAp73
expression levels were significantly increased by metfor-
min treatment (Figure 2E). Next, we investigated whether
TAp73 was responsible for themetformin-induced increase
inNPCproliferation and self-renewal. To assess this, we iso-
lated adult SVZ neurospheres from mice where TAp73 is
specifically knocked out (Tomasini et al., 2008) and treated
them for 6 days with 500 nM metformin. Metformin
enhanced the number of neurosphere-initiating cellsReports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The Authors 989
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Figure 1. Metformin Enhances the Self-
Renewal and Neuronal Differentiation of
Adult Neural Precursors
(A–C) Primary neurospheres cultured from
the adult SVZ were grown in the presence or
absence of 500 nM metformin (Met) and
quantified 6 days later, as pictured in (A).
Scale bar, 200 mm. (B) Quantification of
primary neurosphere (NS) number following
metformin or PBS exposure. ***p% 0.001
(n = 5 for each group). (C) Quantification of
the neurosphere diameter following met-
formin or PBS exposure, as in (A). ***p%
0.001 (pooled data from five independent
experiments).
(D and E) Primary neurospheres were
passaged either once (secondary) or twice
(tertiary) into untreated media, and the
number (D) and diameter (E) of spheres was
quantified 4 days later. ***p% 0.001 (n = 4
for each group).
(F) Quantitative analysis of number of sec-
ondary neurospheres in the absence and
presence of metformin (1 mM). *p < 0.05
(pooled data from four independent exper-
iments).
(G) Immunofluorescence images of bIII-
tubulin (bIII tub)-positive neurons gener-
ated from SVZ adult neurospheres in the
absence and presence of metformin. Arrows
denote bIII-tubulin-positive cells. Scale
bar, 50 mm.
(H) Quantitative analysis of the per-
centage of bIII-tubulin-positive (b III
tubulin+ive) neurons generated in the
absence and presence of metformin
(200 nM), as shown in (G). ***p < 0.001
(pooled data from four independent ex-
periments).
(I–L) In (I) and (K), fluorescence photomicrographs are shown of coronal SVZ (I) and SGZ (K) sections from 3-month-old WT mice that
received PBS or metformin daily by injection (i.p., 200 mg/kg) for 7 days, followed by a single BrdU (100 mg/kg) injection 24 hr before.
Sections were stained for BrdU (green) and counterstained with Hoechst 33258 (blue). Scale bar, 100 mm. (J and L) Quantitative analysis
of total number of BrdU-positive (BrdU+ve) precursor cells within the SVZ (J) and SGZ (L) regions, determined from sections as shown in (I)
and (K). ***p < 0.001 (pooled data from three independent experiments). Arrows denote BrdU-positive cells.
Error bars indicate SEM.
See also Figure S1.cultured from the TAp73+/+ but not TAp73/ SVZ (Figures
2F and 2G). Moreover, when these spheres were passaged,
the TAp73/ cells gave rise to fewer neurospheres, as previ-
ously published (Fujitani et al., 2010), and these numbers
did not increase with metformin treatment (Figure 2H).
To determine whether TAp73 was also required for metfor-
min-mediated NPC self-renewal and proliferation in vivo,
we injected adult TAp73/ mice with metformin and
BrdU, as described earlier, and the number of BrdU-positive
SVZ cells was quantified. This analysis showed that there990 Stem Cell Reports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The Awere fewer BrdU-positive cells in the SVZ of adult
TAp73/ mice as compared to TAp73+/+ mice (Figures 2I
and 2J). Additionally, the number of BrdU-positive cells
in TAp73/ mice was unaffected by metformin adminis-
tration, whereas BrdU-positive cells increased in TAp73+/+
mice treated withmetformin. Similar results were obtained
when we analyzed the other neurogenic zone of the same
mice, the dentate gyrus SGZ (Figure 2K). Thus, TAp73 is
required for the metformin-mediated enhancement of
adult NPC proliferation and self-renewal.uthors
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min-Induced Self-Renewal and Prolifera-
tion of Adult Neural Precursors
(A and B) Primary neurospheres (NSs) were
cultured from the SVZ of adult mice
(3 months old) in the presence or absence of
metformin (Met) and treated with the pan-
PKC inhibitor, chelerythrine. (B) Quantifi-
cation of primary neurospheres following
6 days in culture was done based on repre-
sentative micrographs shown in (A). Scale
bar, 200 mm. **p% 0.01 (pooled data from
four independent experiments).
(C) The SVZ of 3-month-old WT and
CBPS436A-KI mice was dissected and
cultured, and primary neurosphere forma-
tion was quantified 6 days later in the
presence and absence of metformin. **p%
0.01. (pooled data from three independent
experiments).
(D) Metformin- or PBS-treated primary
neurospheres (as in A) from both geno-
types were passaged into untreated media,
and the number of secondary neurospheres
was quantified 4 days later. **p % 0.01.
(pooled data from three independent ex-
periments).
(E) qRT-PCR for TAp73 mRNA performed on
RNA extracted from primary neurospheres
grown in the presence or absence of met-
formin. **p% 0.01 (n = 4 for each group).
(F–H) Primary neurospheres were cultured
from the SVZ of 3-month-old TAp73+/+
and TAp73/ mice in either the presence
or absence of 500 nM metformin. Scale
bar, 200 mm. (G) Quantification of pri-
mary neurospheres from both genotypes
following metformin exposure was done
based on representative micrographs shown
in (F). **p % 0.01 (pooled data from
four independent experiments). (H) Primary
neurospheres cultured with or without metformin (as in A) from both genotypes were passaged into untreated media, and secondary
neurospheres were counted 4 days later. **p% 0.01 (pooled data from four independent experiments).
(I) Confocal micrographs of representative coronal sections through the lateral ventricles of metformin- or PBS-injected TAp73+/+ and
TAp73/mice, stained for BrdU (green) 24 hr after BrdU injection. Sections are counterstained for Hoechst 33258 (blue). Scale bar, 100 mm.
(J and K) Quantification of the total number of BrdU-positive (BrdU+ve) cells in the SVZ (J) and SGZ (K) of metformin- or PBS-treated mice
of both genotypes, as pictured in (I). ***p% 0.001; **p% 0.01 (pooled data from three independent experiments).
Error bars indicate SEM.The AMPK-aPKC-CBP Pathway Mediates the
Metformin-Induced Increase in Neuronal
Differentiation of Adult NPCs andNot Self-Renewal or
Proliferation
Wepreviously demonstrated thatmetformin promoted the
differentiation of embryonic NPCs and that this was in-
hibited by genetic knockdown of either aPKCs or CBP
(Wang et al., 2012). To ask whether this same pathwayStem Cellwas essential for the differentiation of adult NPCs, we
took advantage of two knockin mouse models that spe-
cifically target the aPKC-CBP pathway; the phospho-
mutant CBPS436A-KI mouse and a phospho-competent
p300G422S knockin mouse (p300G422S-KI). p300G422S
encodes a mutationally generated aPKC phosphorylation
site in the CBP homolog p300, which normally lacks this
aPKC site (He et al., 2009, 2012). While the CBPS436AReports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The Authors 991
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Figure 3. Metformin Enhances Neuronal
Differentiation of Adult Neural Precur-
sors by Activating the aPKC-CBP Pathway
(A) Quantification of primary neurosphere
(NS) number cultured from 3-month-old
CBPS436A-KI and p300G422S-KI (KI) mice
(pooled data from four independent exper-
iments).
(B) Quantification of the secondary neuro-
sphere number from CBPS436A-KI and
p300G422S-KI mice in the absence and
presence of metformin (Met). **p < 0.01;
***p < 0.001 (pooled data from four inde-
pendent experiments).
(C) Immunofluorescence images of bIII-
tubulin-positive neurons generated from
SVZ WT and CBPS436A-KI neurospheres in
the absence and presence of metformin.
Arrows denote bIII-tubulin-positive cells.
Scale bar, 20 mm.
(D and E) Quantitative analysis of
the percentage of bIII-tubulin-positive
(b III tubulin+ve) neurons generated
from CBPS436A-KI neurospheres (D) and
p300G422S-KI neurospheres (E), determined
as shown in (C). (pooled data from four in-
dependent experiments).
(F and G) Quantitative analysis of the per-
centage of bIII-tubulin (bIII tub)-positive
neurons generated from SVZ WT and
CBPS436A-KI (F) and p300G422S (G) neu-
rospheres in the absence and presence of
metformin (200 nM). ***p < 0.001; **p <
0.01 (pooled data from four independent
experiments).
(H) Quantitative analysis of the percentage
of bIII-tubulin-positive neurons generated
from SVZ WT, CBPS436A-KI, and p300G422S-
KI neurospheres in the absence and pres-
ence of AICAR (500 nM). *p < 0.05 (pooled
data from four independent experiments).
(I) Immunofluorescence images of GFP-positive, bIII-tubulin-positive neurons generated from SVZ WT neurospheres transfected with CA-
AMPKa1. Arrows denote GFP-positive, bIII-tubulin-positive cells. Scale bar, 20 mm.
(J) Quantification of the percentage of transfected, bIII-tubulin-positive neurons generated from SVZ WT and CBPS436A-KI neurospheres.
EV, empty vector, CA-AMPKa1, constitutively active AMPK a1 subunit. **p < 0.01 (pooled data from four independent experiments).
Error bars indicate SEM.mouse encodes a loss-of-function mutation in the aPKC-
CBP pathway, the p300G422S mouse functioned as an
additional WT control in our experiments.
To determine the effect of aPKC-CBP signaling on the
proliferation, self-renewal, and differentiation of adult
NPCs, we cultured and quantified neurospheres from the
SVZ of adultmice of these different genotypes. The number
and size of neurospheres were similar in all cases (Figures
3A and 3B), suggesting that the aPKC-CBP pathway is992 Stem Cell Reports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The Anot required for NPC self-renewal or proliferation. Then,
we differentiated these neurospheres in the presence
or absence of metformin and quantified the number of
neurons that were generated by immunostaining for
bIII-tubulin (Figure 3C). In the absence of metformin,
CBPS436A-KI and p300G422S-KI neurospheres generated
similar numbers of newborn neurons relative to WT
controls (Figures 3C–3E). In contrast, metformin did
not increase neuronal differentiation from CBPS436A-KIuthors
Figure 4. Model Describing Two Distinct Molecular Pathways
Mediating Metformin-Induced Proliferation/Self-Renewal and
Neuronal Differentiation
TF, transcription factors; Ac, acetylation.neurospheres as it did from control (Figure 3F) or
p300G422S-KI neurospheres (Figure 3G). Thus, metformin
requires the aPKC-CBP pathway to enhance the genesis of
neurons from adult NPCs.
To determine whether the aPKC-CBP pathway was acti-
vated by the metformin target AMPK, we first asked
whether a second AMPK activator, AICAR, had similar
effects as metformin. Quantification showed that 500 nM
AICAR increased the proportion of newborn neurons in
WT and p300G422S-KI cultures (Figure 3H), while it had
no effect on the CBPS436A-KI cultures (Figure 3H). Second,
we overexpressed a constitutively active AMPK alpha1 sub-
unit (CA-AMPKa1) in cultured adult NPCs and observed an
increased in the proportion of newborn neurons inWT but
not CBPS436A-KI cultures (Figures 3I and 3J). Thus, AMPK
activation is sufficient to enhance neurogenesis, and this
requires the aPKC-CBP pathway.DISCUSSION
The data presented here support four major conclusions.
First, metformin treatment enhances the proliferation,
self-renewal, and neuronal differentiation of adult NPCs.
Second, metformin treatment stimulates TAp73 gene
expression in adult NPCs, and TAp73 is required for the
metformin-induced proliferation and self-renewal of adult
NPCs. Third, metformin requires the aPKC-mediated CBP
S436 phosphorylation to induce neuronal differentiation
of adult NPCs. Finally, AMPK activation stimulates adult
NPC neuronal differentiation by activating the aPKC-CBP
pathway.
We previously showed that metformin treatment en-
hancesmurine adultneurogenesis invivowithoutdepleting
the endogenous NPC pool (Wang et al., 2012). This finding
has led to studies to repurpose metformin as a neuroregen-Stem Cellerative agent to treat the injured or degenerating brain (Liu
et al., 2014; Jin et al., 2014). Our findings here provide in-
sights into the molecular mechanisms that regulate the
dual functional roles of metformin in modulating adult
NPC biology. Metformin treatment acts on two distinct mo-
lecular pathways to promote proliferation/regeneration and
differentiation of adult NPCs, respectively. Our previous
study identified TAp73 as an essential protein for adult
NPC self-renewal (Fujitani et al., 2010). Here, we show that
TAp73 is required for metformin to promote the prolifera-
tion and self-renewal of adult NPCs and to expand the
NPC population in vivo. p73 is known to enhance the
expressionof self-renewal genes such as Sox2 andNotch fam-
ily members in embryonic neurospheres (Talos et al., 2010).
TAp73 also is a known tumor suppressor (Irwin et al., 2003),
so the metformin-mediated increase in its activity should
not increase the possibility of tumorigenesis. The second
pathway regulated by metformin is one that we previously
identified in NPCs, the aPKC-CBP pathway (Wang et al.,
2012). This pathway is likely not involved in metformin-
induced NPC proliferation and self-renewal but is essential
for metformin-induced neuronal differentiation. Moreover,
we found that AMPK is an upstream kinase that stimulates
the aPKC-CBP pathway to promote neuronal differentia-
tion. Although the germline AMPK b subunit knockout
mice have been shown to have perturbed embryonic NPC
biology (Dasgupta and Milbrandt, 2009), our study is the
first to assess the role of AMPK activity in adult NPC fate
decisions. Together, these results indicate that metformin
activates two signaling pathways inNPCs: a TAp73 pathway
that mediates self-renewal and proliferation and an AMPK-
aPKC-CBP pathway that is required for neuronal differentia-
tion (Figure 4).
One interesting finding in this study is that initial treat-
ment of metformin in primary neurospheres not only
increases the number and size of primary neurospheres
but also enhances the number and size of secondary and
tertiary neurospheres cultured in the absence of metfor-
min. These data imply that metformin could be used
ex vivo to expand exogenous neural stem cells before trans-
plantation and that these neural stem cells will continually
expand in vivo after transplantation. Therefore, metformin
might be an ideal preconditioning reagent to improve neu-
roregenerative efficiency of transplanted exogenous neural
stem cells in vivo for the treatment of brain injury and
neurodegenerative diseases.
Our study also demonstrates that the aPKC-mediated
single phosphorylation of CBP serves as a signaling sensor
that responds to micro-environmental changes to fine-
tune neuronal differentiation of adult NPCs. This CBP
phosphorylation may directly alter CBP histone acetyl-
transferase activity or chromatin binding. Identification
of downstream targets of the aPKC-CBP pathway at bothReports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The Authors 993
genomic and epigenomic levels will be the subject of our
future work.EXPERIMENTAL PROCEDURES
Animals
All animal use was approved by the animal care committees of the
Hospital for Sick Children and the University of Ottawa in accor-
dance with the Canadian Council of Animal Care policies.
TAp73/, CBPS436A, and p300G422S mice were maintained
on a 12-hr/12-hr light/dark cycle with ad libitum access to food
and water.BrdU Labeling
To quantify proliferating precursors in the SVZ and SGZ, adult
mice were injected i.p. with a single dose of BrdU (Sigma-
Aldrich) at 100 mg/kg. Animals were sacrificed 24 hr later
via sodium pentobarbital overdose and transcardially perfused
with PBS followed by 4% paraformaldehyde. Brains were pro-
cessed for immunostaining as previously described (Wang
et al., 2012), which is detailed in the Supplemental Experi-
mental Procedures.Neurosphere Culture and Transfection
For adult SVZ cultures, the subependyma of the lateral ventricles
was dissected out as previously described (Fujitani et al., 2010).
Cell density and viability were determined via trypan blue exclu-
sion and a hemocytometer. Freshly isolated cells were then plated
at a density of ten cells per microliter in six-well (2 ml per well) ul-
tra-low attachment plates (Corning) in serum-free medium (SFM)
containing 20 ng/ml epidermal growth factor (EGF; Sigma-
Aldrich), 10 ng/ml fibroblast growth factor 2 (FGF2; Sigma-Aldrich),
13 B27 (Becton Dickinson; BD), and 2 mg/ml heparin (Sigma-Al-
drich). Primary neurospheres were counted on day 6 after dissec-
tion, with only spheres composed of over 50 cells being counted.
Sphere diameter was quantified using Northern Eclipse software
(Empix), by drawing a line through the length of each sphere at
6 days of culture. To assess self-renewal, neurospheres were
passaged either once or twice by mechanical dissociation, passed
through a 40-mm cell strainer, plated at a density of two cells per
microliter, and counted 4 days later. All neurosphere experiments
were performed in triplicate wells, and results are representative
of at least three independent experiments. For the differentiation
assay, individual neurospheres were collected, gently triturated,
and plated onto poly-L-ornithine (Sigma)- and laminin (BD)-
coated wells in the presence of 10% FBS with SFM for 7 days. To
assess NPC apoptosis, secondary neurospheres were grouped,
gently triturated, and plated onto poly-L-Ornithine (Sigma) and
laminin (BD)-coated wells in the presence of SFM containing
20 ng/ml EGF, 10 ng/ml FGF2, 13 B27, and 2 mg/ml heparin for
2 days. Metformin stock solution (1 mM) was made in PBS, AICAR
stock solution (5mM)wasmade inDMSO, and chelerythrine stock
solution (1mM)wasmade in DMSO. All these drugs were added to
the cultures at various stages of cultures as indicated. For transfec-
tion, detailed information was described in Supplemental Experi-
mental Procedures.994 Stem Cell Reports j Vol. 5 j 988–995 j December 8, 2015 j ª2015 The AqRT-PCR
qRT-PCR was performed as previously described (Cancino et al.,
2015). Detailed information was described in Supplemental Exper-
imental Procedures.
Immunocytochemistry, Microscopy, and
Quantification
Detailed information is described in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and one figure and can be foundwith this article online
at http://dx.doi.org/10.1016/j.stemcr.2015.10.014.
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